Avsnittsbeskrivning
Could the same genetic data help us develop better medicines and identify disease risk years before symptoms appear?
In this episode of Oxford+ in Partnership with Mishcon de Reya, Susannah de Jager speaks with Sir Peter Donnelly, CEO and co-founder of Genomics, about turning Oxford research into tools for drug discovery and preventative healthcare. Peter explains why assembling public data takes years of careful work, and how human genetics can help scientists choose drug targets and the patients most likely to benefit.
The conversation also examines agentic AI, which lets scientists ask…
Webbplats: share.transistor.fm

